adlitterio66339

About adlitterio66339

This author has not yet filled in any details.
So far adlitterio66339 has created 727 blog entries.

29 08, 2024

Ria Winkelmann et al., Single Center Characterization of a Cohort of Salivary Gland Carcinomas

adlitterio663392024-08-29T11:32:48+02:00

29 08, 2024

Simonetta Maria Leto et al., XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients

adlitterio663392024-08-29T11:21:09+02:00

20 08, 2024

Viola Bianca Serio et al., The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers.

adlitterio663392024-08-20T10:56:31+02:00

11 08, 2024

Lorenzo Nibid et al., RNA-Seq Analysis in Non-Small Cell Lung Cancer: What Is the Best Sample from Clinical Practice?

adlitterio663392024-08-11T11:19:54+02:00

9 08, 2024

Federica Cosso et al., Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma

adlitterio663392024-08-09T11:17:46+02:00

2 08, 2024

Elena Orlandi et al., Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo?immunotherapy: A case report

adlitterio663392024-10-07T11:14:02+02:00

26 07, 2024

Arsenal Sezgin Alikanoglu et al., Detection of High-Risk Human Papillomavirus (HPV), p16 and EGFR in Lung Cancer: Insights from the Mediterranean Region of Turkey

adlitterio663392024-07-26T11:01:07+02:00

11 07, 2024

Shooting Cancer Highlights – Periodic Focus on regulatory status of new targeted therapies in oncology

adlitterio663392024-07-11T14:08:04+02:00

10 07, 2024

Anna Caliò et al., Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma

adlitterio663392024-07-10T10:29:34+02:00

15 05, 2024

Professor Giovanni Scambia joins Diatech Pharmacogenetics’ Scientific Board
Professor Giovanni Scambia joins Diatech Pharmacogenetics’ Scientific Board

News

Professor Giovanni Scambia joins Diatech Pharmacogenetics’ Scientific Board

adlitterio663392024-05-15T16:44:23+02:00

Previous 456 Next